Phebalium ozothamnoides
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Phebalium ozothamnoides |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Phebalium Ozothamnoides |
| Ipni Id | 774741-1 |
| Plant Name | Phebalium Ozothamnoides |
| Genus Tax Id | 77003 |
| Disease Name | Autoimmune disease, Multiple myeloma, Supraventricular tachyarrhythmia, Glaucoma, Migraine, Obesity, Coronary vasospastic disease, Alzheimer disease, Schizoaffective disorder, Thrombocytopenia, Schizophrenia, Indeterminate colitis, Binge eating disorder, Pulmonary hypertension, Coronary atherosclerosis, Pituitary gland disorder, Tension-type headache, Attention deficit hyperactivity disorder, Mental/behavioural/neurodevelopmental disorder, Cough, Heart failure, Thyrotoxicosis, Asthma, Bipolar disorder, Tonus and reflex abnormality, Endometrial cancer, Opioid use disorder, Depression, Anxiety, Chronic insomnia, Idiopathic interstitial pneumonitis, Pain, unspecified, BCR-ABL1-negative chronic myeloid leukaemia, Herpes simplex infection, Breast cancer, Malignant haematopoietic neoplasm, Substance abuse, Functional bladder disorder, Sleep-wake disorder, Parkinsonism, Muscular atrophy, Brain cancer, Endocrine gland neoplasm, Sexual dysfunction, Psychotic disorder, Neurodegenerative disorder, Vasomotor/allergic rhinitis, Gangrene, Cerebral ischaemic stroke, Psychoactive substances use disorder, Diabetic foot ulcer, Intentional self-harm, Psoriasis, Multiple sclerosis, Ischaemic/haemorrhagic stroke, Acute diabete complication, Chronic arterial occlusive disease, Pruritus, Lung cancer, Dementia, Non-specific cutaneous vascular sympton, Chronic pain, Postoperative inflammation, Ventricular tachyarrhythmia, Spinal pain, Choreiform disorder, Crohn disease, Chronic kidney disease, Digestive system disease, Hypotension, Sleep-related breathing disorder, Allergic/hypersensitivity disorder, Chronic obstructive pulmonary disease, Cerebral ischaemia, Skin sensation disturbance, Corneal disease, Mature T-cell lymphoma, Coagulation defect, Post-traumatic stress disorder, Solid tumour/cancer, Cardiac arrhythmia, Conduction disorder, Mild neurocognitive disorder, Gastroduodenal motor/secretory disorder, Carcinoid syndrome, Preterm labour/delivery, Melanoma, Epilepsy/seizure, Stomach cancer, Social anxiety disorder, Skin/mucosal anomaly, Ejaculatory dysfunction, Insomnia, Narcolepsy, Neuropathy, Pancreatic cancer, Mood disorder, Dermal/subcutaneous connective tissue atrophy/degeneration, Bowel habit change, Inborn porphyrin/heme metabolism error, Coronary thrombosis, Type 2 diabetes mellitus, Fragile X chromosome, Dissociative neurological symptom disorder, Rheumatoid arthritis, Angina pectoris, General pain disorder, Sex development malformative disorder, Thrombosis, Juvenile idiopathic arthritis, Acute pain, Cardiovascular disease, Bulimia nervosa, Breathing abnormality, Nausea/vomiting, Bleeding disorder, Restless legs syndrome, Irritable bowel syndrome, Skin and skin-structure infection, Faecal incontinence, Large intestine motility disorder, Abnormal micturition, Central and peripheral nervous disease, Postpartum haemorrhage, Myocardial infarction, Dystonic disorder, Intellectual development disorder, Prostate hyperplasia, Dyspepsia, Sepsis, Prostate cancer, Adaptive immunity immunodeficiency, Acute upper respiratory infection, Essential hypertension, Circulatory system disease, Hyperaemia, Hypoactive sexual desire dysfunction, Itching, Cachexia, Autism spectrum disorder, Nutritional deficiency, Gastro-oesophageal reflux disease, Nasopharyngeal cancer, Prurigo, Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language, Unspecific body region injury, Haemorrhage, not elsewhere classified, Fracture of unspecified body region, Neuropathic pain, Osteoarthritis, Sickle-cell disorder, Obstructive sleep apnoea, Unspecified malignant neoplasms of unspecified sites, Ventricular tachycardia, Neonatal withdrawal syndrome from maternal use of drugs of addiction, Hypospadias, Cardiac arrest, Pulpitis, Chronic rhinosinusitis, Neoplasms, Bronchitis, Rotator cuff syndrome, Ventricular fibrillation, Disorders of cholesterol synthesis, Scoliosis, Malignant neoplasms of stomach, Pregnancy/childbirth/puerperium maternal infection, Preterm newborn, unspecified, Diabetes mellitus, type unspecified, Cholelithiasis, Renal colic, Other specified disorders of the nervous system, Benign smooth muscle or skeletal muscle tumour, Other specified benign neoplasm of endocrine glands, Neoplasms of unknown behaviour of skin, Opioid dependence, unspecified, Osteoarthritis of knee, Shock, Anaphylaxis, Fractures involving multiple body regions, Appendicitis, Head and neck cancer, Dyspnoea, Diseases of the musculoskeletal system or connective tissue, Retention of urine, Oral mucositis, Constipation, Other specified acute tonsillitis, Depressive disorders, unspecified, Other specified abnormalities of breathing, Non-small cell lung cancer, Musculoskeletal system/connective tissue disease, Haemoptysis, Disorders of oral mucosa, Injury of lung, unspecified, Acute myeloid leukaemia, Fracture of rib, Acute myocardial infarction, Type1diabetesmellitus, Gastrointestinal bleeding, unspecified, Other allergic rhinitis, Porokeratoses, Adenocarcinoma, Septic shock, Blood-forming organ disease, Symptoms and signs involving cognition, unspecified, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Idiopathic pulmonary fibrosis, Adenocarcinoma of stomach, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Squamous cell carcinoma of bronchus or lung, Adenocarcinoma of pancreas, Mesothelioma of pleura, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Malignant neoplasms of adrenal gland, Gliomas of brain |
| Genus Name | Phebalium |
| Disease Id | 4A40-4A45, 2A83, BC81, 9C61, 8A80, 5B80-5B81, BA85, 8A20, 6A21, 3B64, 6A20, DD72, 6B82, BB01, BA80, 5A60-5A61, 8A81, 6A05, 6E20-6E8Z, MD12, BD10-BD1Z, 5A02, CA23, 6A60, MB47, 2C76, 6C43, 6A70-6A7Z, MB24.3, 7A00, CB03, MG3Z, 2A41, 1F00, 2C60-2C6Y, 2B33, 6C40, GC50, 7A00-7B2Z, 8A00, 8B61, 2A00, 2F37, HA00-HA01, 6A20-6A25, 8A20-8A23, CA08, MC85, 8B11, 6C4G, BD54, PC91, EA90, 8A40, 8B20, 5A2Y, BD4Z, EC90, 2C25, 6D80-6D8Z, ME64, MG30, 1A00-CA43, BC71, ME84, 8A01, DD70, GB61, DE2Z, BA20-BA21, 7A4Z, 4A80-4A8Z, CA22, 8B1Z, ME65, 9A76-9A78, 2A90, 3B10, 6B40, 2A00-2F9Z, BC9Z, BC63, 6D71, DA41, 5B10, JB00, 2C30, 8A61-8A6Z, 2B72, 6B04, LD27, HA03, 7A00-7A0Z, 7A20, 8C0Z, 2C10, 6A60-6E23, EE40, ME05, 5C58, BA43, 5A11, LD55, 6B60, FA20, BA40, 8.00E+43, LD2A, DB61-GB90, FA24, MG31, BA00-BE2Z, 6B81, MD11, MD90, GA20-GA21, 7A80, DD91, 1F28-1G0Z, ME07, DB32, MF50, 8A04-8E7Z, JA43, BA41-BA43, 8A02, LD90, GA90, MD92, 1G40-1G41, 2C82, 4A01, CA07, BA00, BE2Z, 9A61-9B7Y, HA00, 1F28-1G07, MG20, 6A02, 5B50-5B71, DA22, 2B6B, EC91, 6A02.0, ND56, MG27, ND56.2, 8E43.0, FA00-FA05, 3A51, 7A41, 2D4Z, BC71.0, KD35, LB53, MC82, DA09.0, CA0A, 2, CA20, FB53.1, BC71.1, 5C52.10, FA70.1, JB63, KA21.4Z, 5A14, DC11, MF56, 8E4Y, 2.00E+86, 2F37.Y, 2F92, 6C43.2Z, FA01, MG40, 4A84, ND32, DB10, 2D42, MD11.5, 15, MF50.3, DA01, ME05.0, CA03.Y, 6A7Z, MD11.Y, FC0Z, MD22, NB32.3Z, 2A60, NA82.3, BA41, 5A10, ME24.9Z, CA08.03, ED52, 2D40, XS26, 3C0Z, MB21.Z, 2C76.43, 2C73.4, XH3854, 2A3Z, 1D2Z, 2C15, 2C12.01, 1F54, CB03.4, 2B72.0, 2D60.0, 2A81, 8C71.0, 2C90.Y, 2C25.2, 2C10.0, 2C26.0, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, 4A40.0, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 2D11, 2A00.0 |
| Family Name | Rutaceae |
| Family Tax Id | 23513 |
- 1. (+)-Vitisin C (PubChem CID: 16145527)
- 2. (1ar,4s,4as,7r,7as,7br)-1,1,4,7-Tetramethyl-2,3,4,5,6,7,7a,7b-Octahydro-1ah-Cyclopropa[H]azulen-4a-Ol (PubChem CID: 9794494)
- 3. (1r,2s,4r,5r,6r,7r,10s,11r,14s,16r)-5,14-Dihydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-11-Carbaldehyde (PubChem CID: 11144140)
- 4. (1r,2s,4r,5r,6r,7r,10s,11s,14s,16s)-5,14,16-Trihydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-11-Carbaldehyde (PubChem CID: 163044399)
- 5. (1r,2s,4r,6r,7r,10r,11r,14s,16r)-14-Hydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-11-Carbaldehyde (PubChem CID: 163020390)
- 6. (1r,2s,4r,6r,7r,10s,11s,14s,16s)-14,16-Dihydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-11-Carbaldehyde (PubChem CID: 101286213)
- 7. (1r,2s,4r,6s,7r,10r,11s,16r)-7,11-Dimethyl-6-[(1r,6r)-3-Oxo-2,7-Dioxabicyclo[4.1.0]hept-4-En-6-Yl]-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-One (PubChem CID: 162937370)
- 8. (1s,2r,3's,5s,6s,9s,11r,14r,15s,17r,19r,21r)-2,3',6-Trimethylspiro[16,18-Dioxahexacyclo[15.3.1.02,15.05,14.06,11.015,19]henicosane-21,2'-Oxirane]-9-Ol (PubChem CID: 72701755)
- 9. (1s,2r,5r,7s,10s,11s,12s,14r,15r,16s,17r)-7,12-Dihydroxy-10,14,17-Trimethyl-13-Oxo-18-Oxapentacyclo[13.3.2.01,14.02,11.05,10]icosane-16-Carbaldehyde (PubChem CID: 46939055)
- 10. (1s,2r,5s,7s,10r,11s,14r,15r)-16-Ethenyl-10,14-Dimethyl-18-Oxapentacyclo[13.3.2.01,14.02,11.05,10]icos-16-Ene-5,7-Diol (PubChem CID: 72702445)
- 11. (1s,2r,5s,7s,10r,11s,14r,15r,16s,17r)-5,7-Dihydroxy-10,14,17-Trimethyl-18-Oxapentacyclo[13.3.2.01,14.02,11.05,10]icosane-16-Carbaldehyde (PubChem CID: 46939054)
- 12. (2r,5r)-2-Propan-2-Yl-5-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-Trihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]hexanoic Acid (PubChem CID: 162884008)
- 13. (2s)-2-[[4-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-4-Oxobutanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 163189854)
- 14. (2s)-2-[[4-[[(3s,5r,8r,9s,10s,13r,14s,16r,17r)-16-Acetyloxy-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-4-Oxobutanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 162925487)
- 15. (2s)-2-[[4-[[(3s,5r,8r,9s,10s,13r,14s,16s,17r)-16-Acetyloxy-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-4-Oxobutanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 162925488)
- 16. (2s)-2-[[5-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-5-Oxopentanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 163044499)
- 17. (2s)-2-[[6-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16s)-5-Acetyloxy-11-Formyl-16-Hydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-6-Oxohexanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 53253803)
- 18. (2s)-2-[[7-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-7-Oxoheptanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 162895547)
- 19. (2s)-2-[[7-[[(3s,5r,8r,9s,10s,13r,14s,16s,17r)-16-Acetyloxy-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-7-Oxoheptanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 46930230)
- 20. (2s)-2-[[8-[[(1r,2s,4r,5r,6r,7r,10s,11r,14s,16s)-5-Acetyloxy-16-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-8-Oxooctanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 163055984)
- 21. (2s)-2-[[8-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-8-Oxooctanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 102003563)
- 22. (2s)-2-[[9-[[(1r,2s,4r,5r,6r,7r,10s,11r,14s,16s)-5-Acetyloxy-16-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-9-Oxononanoyl]amino]-5-(Diaminomethylideneamino)pentanoic Acid (PubChem CID: 46930229)
- 23. (2s)-5-(Diaminomethylideneamino)-2-[[4-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-4-Oxobutanoyl]amino]pentanoic Acid (PubChem CID: 162869037)
- 24. (2s)-5-(Diaminomethylideneamino)-2-[[4-[[(1r,2s,4r,6r,7r,10s,11s,14s,16r)-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-4-Oxobutanoyl]amino]pentanoic Acid (PubChem CID: 102574724)
- 25. (2s)-5-(Diaminomethylideneamino)-2-[[4-[[(3s,5r,8r,9s,10s,11r,13r,14s,17r)-11,14-Dihydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-4-Oxobutanoyl]amino]pentanoic Acid (PubChem CID: 163193221)
- 26. (2s)-5-(Diaminomethylideneamino)-2-[[4-[[(3s,5r,8r,9s,10s,13r,14s,17r)-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-4-Oxobutanoyl]amino]pentanoic Acid (PubChem CID: 102595428)
- 27. (2s)-5-(Diaminomethylideneamino)-2-[[4-[[(3s,5s,8s,9s,10r,13r,14s,17r)-5,14-Dihydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]oxy]-4-Oxobutanoyl]amino]pentanoic Acid (PubChem CID: 163003878)
- 28. (2s)-5-(Diaminomethylideneamino)-2-[[8-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10-Formyl-5,14-Dihydroxy-13-Methyl-17-(6-Oxopyran-3-Yl)-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]oxy]-8-Oxooctanoyl]amino]pentanoic Acid (PubChem CID: 163070148)
- 29. (3r,5r,7r,8r,9s,10s,12s,13r,14s,17r)-17-[(2r,6s)-7-Hydroxy-6-Methylheptan-2-Yl]-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthrene-3,7,12-Triol (PubChem CID: 163000902)
- 30. (3r,5r,7r,8r,9s,10s,12s,13r,14s,17r)-17-[(2s,5r)-5,6-Dihydroxy-5,6-Dimethylheptan-2-Yl]-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthrene-3,7,12-Triol (PubChem CID: 163039748)
- 31. (3r,5s,8r,9s,10s,13r,14s,17r)-3,5,14-Trihydroxy-13-Methyl-17-(6-Oxopyran-3-Yl)-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthrene-10-Carbaldehyde (PubChem CID: 163064957)
- 32. (3s,5s,8s,9s,10s,13r,14s,17r)-3,5,14-Trihydroxy-13-Methyl-17-(6-Oxopyran-3-Yl)-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthrene-10-Carbaldehyde (PubChem CID: 163064956)
- 33. (3s,7s,8s,9s,10r,13r,14s,17r)-10,13-Dimethyl-17-[(2s)-6-Methylheptan-2-Yl]-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthrene-3,7-Diol (PubChem CID: 15571096)
- 34. (3ss,5ss)-3-Hydroxycholan-24-Oic Acid (PubChem CID: 92849605)
- 35. (7,7-Dimethyl-2-Aza-7-Azoniatricyclo[6.3.1.04,12]dodeca-1(12),3,8,10-Tetraen-9-Yl) Sulfate (PubChem CID: 12302124)
- 36. (E,2r,3r,6s)-2,3-Dimethyl-6-[(3r,5r,7r,8s,9s,10s,12s,13s,14r,17r)-3,7,12-Trihydroxy-10-Methyl-1,2,3,4,5,6,7,8,9,11,12,13,14,15,16,17-Hexadecahydrocyclopenta[A]phenanthren-17-Yl]hept-4-Enoic Acid (PubChem CID: 162958224)
- 37. (E,2r,6r)-2-Methyl-6-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-Trihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]hept-3-Enoic Acid (PubChem CID: 162909278)
- 38. (E,2s,5r)-2-Propan-2-Yl-5-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-Trihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]hex-3-Enoic Acid (PubChem CID: 162887790)
- 39. 1-[(2r)-2-Hydroxy-2-(4-Hydroxyphenyl)ethyl]-1-Methylurea (PubChem CID: 162945066)
- 40. 12beta-Hydroxyresibufogenin (PubChem CID: 15513541)
- 41. 19-Hydroxydesacetylcinobufagin (PubChem CID: 15513543)
- 42. 19-Hydroxyresibufogenin (PubChem CID: 12314891)
- 43. 19-Oxobufalin (PubChem CID: 10883889)
- 44. 19-Oxocinobufotalin (PubChem CID: 102093790)
- 45. 1beta-Hydroxybufalin (PubChem CID: 10993111)
- 46. 2-(5-Hydroxy-1h-Indol-3-Yl)ethylurea (PubChem CID: 70959828)
- 47. 20r,21-Epoxyresibufogenin (PubChem CID: 10092398)
- 48. 20s,21-Epoxy-Resibufogenin Formate (PubChem CID: 11026341)
- 49. 20s,21-Epoxyresibufogenin (PubChem CID: 10453620)
- 50. 22,23-Dihydrobrassicasterol (PubChem CID: 5283637)
- 51. 3-Epi-Resibufogenin (PubChem CID: 70684536)
- 52. 3-Hydroxy-1-(4-Hydroxy-3,5-Dimethoxyphenyl)-1-Propanone (PubChem CID: 75142)
- 53. 4-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-4-Oxobutanoic Acid (PubChem CID: 162905120)
- 54. 4-[[(1r,2s,4r,6r,7r,10s,11s,14s,16r)-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-4-Oxobutanoic Acid (PubChem CID: 162962369)
- 55. 4-Hydroxybenzyl Alcohol (PubChem CID: 125)
- 56. 4-O-[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl] 1-O-Methyl Butanedioate (PubChem CID: 163037743)
- 57. 4-O-[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl] 1-O-Methyl Butanedioate (PubChem CID: 163066396)
- 58. 4-O-[(1r,2s,4r,6r,7r,10s,11s,14s,16r)-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl] 1-O-Methyl Butanedioate (PubChem CID: 162954496)
- 59. 5-[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16s)-5,11,14,16-Tetrahydroxy-7-Methyl-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-6-Yl]pyran-2-One (PubChem CID: 46939053)
- 60. 5-[(1r,2s,4r,5s,6r,7r,10s,11s,14s,16r)-5,14-Dihydroxy-7,11-Dimethyl-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-6-Yl]pyran-2-One (PubChem CID: 12186697)
- 61. 5-[(1r,2s,4r,6r,7r,10r,11s,14s,16r)-14-Hydroxy-7,11-Dimethyl-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-6-Yl]pyran-2-One (PubChem CID: 122173140)
- 62. 5-[(1r,3r,5r,8r,9s,10s,11s,13r,14s,17r)-1,3,11,14-Tetrahydroxy-10,13-Dimethyl-12-Oxo-2,3,4,5,6,7,8,9,11,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 46938951)
- 63. 5-[(1r,3s,5s,8r,9s,10s,13r,14s,17r)-1,3,5,14-Tetrahydroxy-10,13-Dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 162968115)
- 64. 5-[(3s,5r,8r,9s,10s,11r,13r,14s,17s)-3,11,14-Trihydroxy-10,13-Dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 163087103)
- 65. 5-[(3s,5r,8r,9s,10s,12r,13s,14s,16s,17r)-3,12,14,16-Tetrahydroxy-10,13-Dimethyl-11-Oxo-2,3,4,5,6,7,8,9,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 46938952)
- 66. 5-[(3s,5r,8r,9s,10s,13r,14s,17s)-3-Hydroxy-10,13-Dimethyl-15-Oxo-1,2,3,4,5,6,7,8,9,11,12,14,16,17-Tetradecahydrocyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 12308599)
- 67. 5-[(3s,5r,9r,10s,13r,16s,17s)-3,16-Dihydroxy-10,13-Dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 46938954)
- 68. 5-[(3s,5s,8r,9r,10r,12r,13s,14s,17r)-3,5,12,14-Tetrahydroxy-13-Methyl-11-Oxo-2,3,4,6,7,8,9,10,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 163087096)
- 69. 5-[(3s,5s,8r,9r,10r,12s,13s,14s,17r)-3,5,12,14-Tetrahydroxy-13-Methyl-11-Oxo-2,3,4,6,7,8,9,10,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 163087095)
- 70. 5-[(3s,5s,8r,9s,10r,13r,14s,17s)-3,5-Dihydroxy-10,13-Dimethyl-15-Oxo-2,3,4,6,7,8,9,11,12,14,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 46938950)
- 71. 5-[(5r,8r,9s,10s,11r,13r,14r,17r)-11,14-Dihydroxy-10,13-Dimethyl-3-Oxo-2,4,5,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]pyran-2-One (PubChem CID: 162975519)
- 72. 5beta-Dermophol (PubChem CID: 5284186)
- 73. 7,7-Dimethyl-2-Aza-7-Azoniatricyclo[6.3.1.04,12]dodeca-1(12),3,8,10-Tetraen-9-Olate (PubChem CID: 5316436)
- 74. 8-[2-(5-Hydroxy-1h-Indol-3-Yl)ethylamino]-8-Oxooctanoic Acid (PubChem CID: 101460861)
- 75. 8-[[(1r,2s,4r,5r,6r,7r,10s,11s,14s,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-8-Oxooctanoic Acid (PubChem CID: 70697081)
- 76. 8-[[(1s,2s,4r,5r,6r,7r,10s,11r,14r,16r)-5-Acetyloxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl]oxy]-8-Oxooctanoic Acid (PubChem CID: 162926007)
- 77. 8-[[(3s,5r,8r,9s,10s,11r,13r,14s,17r)-11,14-Dihydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-8-Oxooctanoic Acid (PubChem CID: 162952112)
- 78. 8-[[(3s,5r,8r,9s,10s,13r,14s,17r)-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-3-Yl]oxy]-8-Oxooctanoic Acid (PubChem CID: 67050194)
- 79. 8-[[(3s,5s,8s,9s,10r,13r,14s,17r)-5,14-Dihydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-2,3,4,6,7,8,9,11,12,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]oxy]-8-Oxooctanoic Acid (PubChem CID: 163092461)
- 80. 8-Demethyleucalyptin (PubChem CID: 15715157)
- 81. 9,12-Di-O-Methylsubamol (PubChem CID: 71461983)
- 82. [(1r,2s,4r,5r,6r,7r,10s,11s,14s,16s)-11,14,16-Trihydroxy-7-Methyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-Yl] Acetate (PubChem CID: 49818154)
- 83. [(1r,2s,4r,5r,6r,7r,10s,11s,14s,17s)-11,14-Dihydroxy-7-Methyl-16-Oxo-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,17]octadecan-5-Yl] Acetate (PubChem CID: 49818075)
- 84. [(1r,2s,4r,5r,6r,7r,10s,12r,14s,16r)-14,16-Dihydroxy-7-Methyl-11-Oxo-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.012,16]octadecan-5-Yl] Acetate (PubChem CID: 49818153)
- 85. [(1r,2s,4r,5r,6r,7s,8r,10r,11s,14s,16r)-8,14-Dihydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-Yl] Acetate (PubChem CID: 163018662)
- 86. [(1r,2s,4r,5r,6s,7r,10s,11s,14s,16r)-14-Hydroxy-7,11-Dimethyl-6-[(Z)-1-Oxobut-2-En-2-Yl]-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-Yl] Acetate (PubChem CID: 72702443)
- 87. [(1r,2s,4r,5s,6r,7r,10s,11r,14s,16s)-14,16-Dihydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-Yl] Acetate (PubChem CID: 162880256)
- 88. [(1r,2s,4r,5s,6r,7r,10s,11s,14s,16r)-14-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-5-Yl] Acetate (PubChem CID: 44559632)
- 89. [(1r,2s,4r,6r,7r,10r,11s,14s,16r)-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl] Formate (PubChem CID: 163025386)
- 90. [(1r,2s,4r,6r,7r,10s,11s,14s,16r)-7,11-Dimethyl-6-[(1r,6r)-3-Oxo-2,7-Dioxabicyclo[4.1.0]hept-4-En-6-Yl]-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-14-Yl] Formate (PubChem CID: 154731852)
- 91. [(1s,2r,5r,7s,10s,11s,14r,15r,20s)-16-Ethenyl-7-Hydroxy-10,14-Dimethyl-18-Oxapentacyclo[13.3.2.01,14.02,11.05,10]icos-16-En-20-Yl] Acetate (PubChem CID: 72702444)
- 92. [(3s,5r,8r,9s,10s,13r,14s,16r,17r)-3,14-Dihydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-Tetradecahydrocyclopenta[A]phenanthren-16-Yl] Acetate (PubChem CID: 44559630)
- 93. [(8r,9s,10r,13r,14s,16s,17r)-14-Hydroxy-10,13-Dimethyl-17-(6-Oxopyran-3-Yl)-1,2,3,4,7,8,9,11,12,15,16,17-Dodecahydrocyclopenta[A]phenanthren-16-Yl] Acetate (PubChem CID: 46938953)
- 94. [7-Oxo-7-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyheptyl] (1r,2s,4r,6r,7r,10s,11r,14r,16s)-16-Hydroxy-7,11-Dimethyl-6-(6-Oxopyran-3-Yl)-3-Oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecane-14-Carboxylate (PubChem CID: 162928621)
- 95. Beta-Farnesene, (6z)- (PubChem CID: 5317319)
- 96. Beta-Sitosterol (PubChem CID: 222284)
- 97. Bufa-20,22-Dienolide, 3-((8-((4-((Aminoiminomethyl)amino)-1-Carboxybutyl)amino)-1,8-Dioxooctyl)oxy)-14-Hydroxy-, (3beta(S),5beta)- (PubChem CID: 99882)
- 98. Bufalin (PubChem CID: 9547215)
- 99. Bufarenogin (PubChem CID: 167607)
- 100. Bufobutanoic Acid (PubChem CID: 10612485)
- 101. Bufogenin (PubChem CID: 6917974)
- 102. Bufogenin B (PubChem CID: 12358889)
- 103. Bufoserotonin C (PubChem CID: 101460862)
- 104. Bufotalin (PubChem CID: 12302120)
- 105. Bufotenidine (PubChem CID: 3083591)
- 106. Bufotenin (PubChem CID: 10257)
- 107. Bufotenin Oxide (PubChem CID: 3083669)
- 108. Bufotoxin (PubChem CID: 20054854)
- 109. Caryophyllene (PubChem CID: 5281515)
- 110. Cholesterol (PubChem CID: 5997)
- 111. Cinobufagin (PubChem CID: 11969542)
- 112. Cinobufagin-3-Hemisuccinate (PubChem CID: 11969464)
- 113. Cinobufaginol (PubChem CID: 12303266)
- 114. Cinobufotalin (PubChem CID: 259776)
- 115. Cis-P-Mentha-1(7),8-Dien-2-Ol (PubChem CID: 6429040)
- 116. Desacetylcinobufagin (PubChem CID: 11877495)
- 117. Desacetylcinobufotalin (PubChem CID: 15513544)
- 118. Dotriacontane (PubChem CID: 11008)
- 119. Epicatechin (PubChem CID: 72276)
- 120. Epinephrine (PubChem CID: 5816)
- 121. Ethyl Vanillin (PubChem CID: 8467)
- 122. Furcatin (PubChem CID: 442789)
- 123. Gamabufotalin (PubChem CID: 259803)
- 124. Hellebrigenin (PubChem CID: 259577)
- 125. Hellebrigenin 3-Acetate (PubChem CID: 267436)
- 126. Humulene (PubChem CID: 5281520)
- 127. Hyperoside (PubChem CID: 5281643)
- 128. Loliolide (PubChem CID: 100332)
- 129. Marinobufagenin (PubChem CID: 11969465)
- 130. Methyl 4-[(3s,5r,8r,9s,10s,13s)-3-Hydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12-Decahydro-1h-Cyclopenta[A]phenanthren-17-Yl]-4-Oxobutanoate (PubChem CID: 72701756)
- 131. Miyabenol A (PubChem CID: 16129868)
- 132. Morphine (PubChem CID: 5288826)
- 133. N-Methylserotonin (PubChem CID: 150885)
- 134. Oxyphyllenodiol A (PubChem CID: 10082923)
- 135. Palmitic Acid (PubChem CID: 985)
- 136. Phlorizin (PubChem CID: 6072)
- 137. Pseudobufarenogin (PubChem CID: 204810)
- 138. Rosavin (PubChem CID: 9823887)
- 139. Rutin (PubChem CID: 5280805)
- 140. Serotonin (PubChem CID: 5202)
- 141. Stearic Acid (PubChem CID: 5281)
- 142. Stigmasterol Glucoside (PubChem CID: 6602508)
- 143. Subamolide B (PubChem CID: 16104907)
- 144. Subavenoside A (PubChem CID: 71453067)
- 145. Telocinobufagin (PubChem CID: 259991)
- 146. Telocinobufatoxin (PubChem CID: 156077)
- 147. Tryptamine (PubChem CID: 1150)
- 1. Adenocarcinoma
- 2. Alzheimer's Disease 1
- 3. Appendicitis
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Bronchitis
- 7. Cardiovascular Diseases
- 8. Cholelithiasis
- 9. Cholera
- 10. Constipation
- 11. Crohn Disease
- 12. Dementia
- 13. Diabetes Mellitus
- 14. Diabetes Mellitus, Type 1
- 15. Epilepsy
- 16. Glaucoma
- 17. Hematologic Diseases
- 18. Lupus Erythematosus, Systemic
- 19. Musculoskeletal Diseases
- 20. Myocardial Infarction
- 21. Nervous System Diseases
- 22. Obesity
- 23. Psoriasis
- 24. Psychotic Disorder
- 25. Skin Neoplasms
- 26. Stomatitis
- 27. Thrombocytopenia
Not listed in any formulations.